This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
gga-miR-19b-3pMIMAT0001110 0.0e+0 1.1e-1Epididymosomes convey different repertoires of microRNAs throughout the bovine epididymis.
Biol Reprod. 2013 Aug 15;89(2):30. doi: 10.1095/biolreprod.113.110486. Print 2013 Aug.		MIPF0000011_275 / 0 / 75
mdo-miR-19b-3pMIMAT0004170 0.0e+0 1.0e-1Epididymosomes convey different repertoires of microRNAs throughout the bovine epididymis.
Biol Reprod. 2013 Aug 15;89(2):30. doi: 10.1095/biolreprod.113.110486. Print 2013 Aug.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 3.9e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 3.8e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 3.9e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 3.9e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18389. eCollection 2012.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 3.1e-3 1.8e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 2.8e-3 2.4e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 5.9e-4 5.4e-2Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 1.5e-3 2.1e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 2.2e-3 2.1e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 2.5e-3 2.4e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 1.7e-3 2.0e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 3.0e-3The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.1e-5The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 6.2e-3The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.1e-5The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 1.3e-1The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 8.0e-4The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 2.4e-1The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.8e-4The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 1.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 5.0e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.2e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.1e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.9e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.7e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.2e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.8e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.6e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.5e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.4e-1MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 3.0e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 2.8e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 1.2e-4 4.5e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 3.7e-4 4.7e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 2.3e-4 4.8e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 2.7e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 2.1e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 4.8e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.6e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 2.0e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 2.0e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.5e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 5.5e-6Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 1.4e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 8.0e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 1.4e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
tgu-miR-19a-3pMIMAT0014611 0.0e+0 9.3e-4Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 1.3e-4Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 2.9e-6Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 9.3e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 9.9e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
tgu-miR-19a-3pMIMAT0014611 0.0e+0 9.3e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 6.5e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 2.0e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.9e-1Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles includes microRNA-like tRNA Fragments.
Mol Cancer Res. 2015 Feb 26. pii: molcanres.0533.2014.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 2.7e-1Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000011_275 / 0 / 75
mmu-miR-19b-3pMIMAT0000513 0.0e+0 2.0e-1Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 3.1e-1Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000011_275 / 0 / 75
mmu-miR-19b-3pMIMAT0000513 0.0e+0 2.5e-1Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 1.7e-1Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing.
RNA Biol. 2016 Oct 28:0.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 8.3e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 2.0e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 7.9e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.4e-2Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0000011_275 / 0 / 75
gga-miR-19b-3pMIMAT0001110 0.0e+0 1.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000011_275 / 0 / 75
mmu-miR-19b-3pMIMAT0000513 0.0e+0 1.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000011_275 / 0 / 75
oan-miR-19b-3pMIMAT0006856 0.0e+0 1.4e-1Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 4.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 2.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 4.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 1.6e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000011_275 / 0 / 75
mmu-miR-19b-3pMIMAT0000513 0.0e+0 1.2e-10Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000011_275 / 0 / 75
mmu-miR-19a-3pMIMAT0000651 0.0e+0 1.3e-8Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000011_275 / 0 / 75
< [2] [3]